(Q42997762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Efficacy of interferon therapy in elderly patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

13

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

5

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

8

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

11

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

Satoshi Saitoh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

12

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

9

Takashi Someya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Rikako Koyama

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

121-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16428887%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

15 January 2020

cites work

1 reference

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

21 January 2018

1 reference

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study

21 January 2018

1 reference

Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease

21 January 2018

1 reference

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

21 January 2018

1 reference

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

21 January 2018

1 reference

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

21 January 2018

1 reference

Side effects of high-dose interferon therapy for chronic hepatitis C.

21 January 2018

1 reference

Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis.

21 January 2018

1 reference